trending Market Intelligence /marketintelligence/en/news-insights/trending/yhBwroNDAyLLn4q99WmpuQ2 content esgSubNav
In This List

Blueprint Medicines to raise $150M via share offering

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Blueprint Medicines to raise $150M via share offering

Blueprint Medicines Corp. is looking to raise $150 million to advance its drug pipeline for the treatment of advanced solid tumors.

The company plans to issue shares in an underwritten public offering, which will be priced at a later date. Underwriters will have an option to purchase up to an additional $22.5 million of the shares offered.

Goldman Sachs & Co., Morgan Stanley and Cowen and Co. will serve as joint book-running managers for the offering; Raymond James will act as co-manager.